SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$45.50
-0.59 (-1.28%)
As of Nov 5, 9:54 PM ET ·
SRRK News1 articles
Scholar Rock's Isembyld Approval Fuels Launch Test, Shares Slip
Scholar Rock's stock dropped 4.6% after FDA approval of Isembyld, its first drug for SMA. The focus shifts from regulatory approval to commercial launch execution.
Analysis